Press Releases
The Board of Directors approves the net financial position for the first quarter of 2021
The Board of Directors approves the net financial position for the first quarter of 2021 in the amount of 104,668 thousand euro, and acknowledges the progress of the main clinical...
Read moreIl Consiglio di Amministrazione approva la posizione finanziaria netta relativa al primo trimestre 2021
Il Consiglio di Amministrazione approva la posizione finanziaria netta relativa al primo trimestre 2021, positiva pari a euro 104.668 migliaia, e prende atto dello stato di avanzamento dei trials principali...
Read morePhilogen announces publication of best-in-class FAP-targeting small molecule ligand (OncoFAP) in PNAS
Study shows impressive tumor uptake of OncoFAP with unprecedented selectivity against healthy organs. OncoFAP-based molecules are currently being developed for the imaging and therapy of cancer. Philogen announces participation to...
Read moreUpcoming Events
Past Events
Philogen to Attend the European Society for Medical Oncology 2021 Conference on September 16-19, 2021
Philogen announces its participation at the European Society for Medical Oncology 2021 Conference taking place on September 16-19, 2021. Philogen is presenting Nidlegy’s™ clinical developments in Melanoma and Non Melanoma Skin...
Read morePhilogen to organise a non-deal Roadshow with Investors on July 5-7, 2021
Philogen announces the organization of a non-deal Roadshow with Investors on July 5-7, 2021. The event will be organised together with Mediobanca, Goldman Sachs and Stifel.
Philogen to attend the 11th Post-Chicago Meeting on Melanoma / Skin Cancer on July 8-9, 2021
Philogen announces its participation at the virtual 11th Post-Chicago Meeting on Melanoma / Skin Cancer organised by the European Association of Dermatology-Oncology and the Melanoma World society taking place on July 8-...
Read more